Can You Take Wegovy Every Two Weeks? The Dosing Schedule Explained

Wegovy (semaglutide) is a once-weekly subcutaneous injection; the seven-day interval between doses is part of the licensed dosing schedule, not a rough guide.
Taking doses further apart than weekly can lead to a drop in the drug's steady-state concentration, meaning the appetite-regulating effects may weaken noticeably.
Restarting after a gap of two or more weeks often brings a return of the gastrointestinal side effects that typically settle after the first few injections.
If an injection is genuinely missed, the Patient Information Leaflet and your prescriber (not a general estimate) are the right sources for what to do next.

No — Wegovy is not licensed or designed for a fortnightly injection. The prescribed schedule is once weekly, every seven days, and that timing is not flexible. Stretching doses to every two weeks reduces the medicine's effectiveness and may increase side effects when you restart. If weekly injections feel difficult to manage (whether that's around holidays, work patterns or simply remembering) the right answer is to speak to your prescriber rather than adjust the interval yourself. As a prescription-only medicine, Wegovy requires a clinical assessment before treatment begins, and any change to how it's used should involve the clinician overseeing your care.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Why the Weekly Schedule Matters — and What Happens When It Slips

The myth: fortnightly injections are a lower-risk, gentler option

It's a reasonable assumption. If weekly injections sometimes cause nausea, surely spacing them out would be easier on the body? In practice, the opposite tends to be true. Semaglutide works by maintaining a relatively stable concentration in the bloodstream, its half-life of around one week is precisely why once-weekly dosing was chosen. Inject every two weeks and that concentration falls well below the therapeutic range before the next dose arrives. The appetite-suppressing effect fades, hunger returns more sharply, and when you do inject again, the body responds to a larger relative change in drug levels. That rebound is one of the main reasons nausea and other gastrointestinal symptoms can feel worse after a gap rather than better. So the idea that a longer interval is gentler is, unfortunately, a misconception. The NHS medicines guidance on semaglutide is clear that the medicine is taken once a week on the same day each week, and that the day can be changed if needed, but only if the minimum interval between any two doses remains at least four days. Two weeks is not a variation within the schedule; it takes treatment effectively off-course.

What the licensed schedule actually looks like, and where two weeks fits in

Wegovy's titration pathway starts at 0.25 mg and moves through 0.5 mg, 1.0 mg and 1.7 mg before reaching the 2.4 mg maintenance dose, with roughly four weeks at each level under prescriber guidance. From April 2026, the MHRA also approved a 7.2 mg single-dose pen for eligible adults with a BMI of 30 or above, reached through the same step-by-step escalation. Throughout all of this, the injection frequency stays the same: once a week. If you're curious about eligibility thresholds (including what BMI criteria apply and how comorbidities affect the picture) our overview of BMI requirements for Wegovy covers those in detail. The only place where two weeks becomes a number worth knowing is the fortnightly prescription refill cycle some services use. That's an administrative interval, not a clinical dosing one. The pen itself contains four weekly doses; the schedule continues as normal while you wait for the next supply. Keeping that distinction in mind avoids confusion, a question our prescribers hear reasonably often, particularly around bank holidays and payday cycles when people order slightly later than planned.

What actually helps if weekly injections feel hard to sustain

The practical barriers to weekly injections are real. A holiday where fridge storage isn't straightforward, a chaotic week, a stretch where motivation dips, none of these are unusual, and they're worth raising with whoever is managing your treatment. The licensed room-temperature storage window for Wegovy (exact duration in the Patient Information Leaflet) gives some flexibility for travel. Changing your injection day is permitted as long as that four-day minimum gap is kept. If you're finding the routine genuinely hard to stick to, the oral alternative may be worth exploring: the Wegovy overview page covers both the injection and the tablet form, which received MHRA approval in June 2026 as the UK's first oral GLP-1 medicine licensed for weight management. It's taken once daily rather than once weekly, which some people find easier to build into a morning routine. Whether injection or tablet suits you better is a clinical question, not just a practical one, it depends on your health picture, your history with the medicine, and what the prescriber reviewing your case concludes. If you'd like to understand more about how the two options compare, our weight-loss treatments page gives a clear side-by-side. For context on private treatment costs, the Wegovy price comparison page explains what different services typically include in their pricing.

Missed a dose? Here's the short version, and where to go for the full answer

If you realise you've missed an injection, the first place to look is the Patient Information Leaflet that came with your pen, which covers the specific timing rules. The general principle, as set out in NHS guidance on semaglutide, is that a missed dose can be taken within five days of when it was due; if more than five days have passed, skip it and continue with the next scheduled dose on its usual day. Do not take two doses in one week to make up for a missed one. Beyond that general framework, the specifics of what to do (particularly if you are mid-titration, have had a longer gap, or are unsure whether to restart at a lower dose) are decisions for your prescriber. Attempting to self-adjust the frequency, whether by injecting earlier or later than intended, is not covered by the licensed schedule and could affect both safety and results. Related questions about timing variations are answered in our pages on taking Wegovy every five days, every six days, and every other week, each looks at a slightly different scenario. The consistent answer across all of them is the same: the seven-day interval is the schedule, and deviating from it is a clinical conversation, not a personal calculation. If you'd like to check your own eligibility for treatment and speak with a prescriber, you can check your eligibility through a free consultation with the team at nume.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions